We have located links that may give you full text access.
Preliminaries to Treatment Recommendations in UK Primary Care: A Vehicle for Shared Decision Making?
Health Communication 2018 November
This paper focuses on a recurrent practice observed in UK primary care data - how physicians use pre-recommendations: action sequences that when initiated post-diagnosis are recognisably preliminary to the drug treatment recommendations that they contingently project. Data are drawn from recorded primary care consultations collected in England. Pre-recommendations consist of physician requests for information about prior medicines such as, What've you tried taking? or Have you taken anything so far? Patient responses subsequently shape the first part of the base treatment recommendation pair. These preliminaries can help physicians manage potential obstacles to patient acceptance: by avoiding prescribing something a patient is already taking, or has tried and found to be ineffective, and by accommodating concerns such as side effects or practical barriers to acceptance. Pre-recommendations are a strategy for convincing/persuading whilst allowing physicians to avoid making an ill-fitted recommendation that might be resisted or rejected as unwanted or unnecessary.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app